1. Home
  2. BRTX vs PT Comparison

BRTX vs PT Comparison

Compare BRTX & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • PT
  • Stock Information
  • Founded
  • BRTX 1997
  • PT 2012
  • Country
  • BRTX United States
  • PT China
  • Employees
  • BRTX N/A
  • PT N/A
  • Industry
  • BRTX Managed Health Care
  • PT Computer Software: Programming Data Processing
  • Sector
  • BRTX Health Care
  • PT Technology
  • Exchange
  • BRTX Nasdaq
  • PT Nasdaq
  • Market Cap
  • BRTX 12.8M
  • PT 14.7M
  • IPO Year
  • BRTX N/A
  • PT 2018
  • Fundamental
  • Price
  • BRTX $1.54
  • PT $1.04
  • Analyst Decision
  • BRTX
  • PT
  • Analyst Count
  • BRTX 0
  • PT 0
  • Target Price
  • BRTX N/A
  • PT N/A
  • AVG Volume (30 Days)
  • BRTX 331.3K
  • PT 116.4K
  • Earning Date
  • BRTX 11-13-2025
  • PT 09-19-2025
  • Dividend Yield
  • BRTX N/A
  • PT N/A
  • EPS Growth
  • BRTX N/A
  • PT N/A
  • EPS
  • BRTX N/A
  • PT N/A
  • Revenue
  • BRTX $605,200.00
  • PT $4,961,892.00
  • Revenue This Year
  • BRTX $232.67
  • PT N/A
  • Revenue Next Year
  • BRTX $52.92
  • PT N/A
  • P/E Ratio
  • BRTX N/A
  • PT N/A
  • Revenue Growth
  • BRTX 247.62
  • PT 9.20
  • 52 Week Low
  • BRTX $1.19
  • PT $0.76
  • 52 Week High
  • BRTX $2.55
  • PT $1.38
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 47.02
  • PT 62.96
  • Support Level
  • BRTX $1.49
  • PT $0.93
  • Resistance Level
  • BRTX $1.70
  • PT $1.01
  • Average True Range (ATR)
  • BRTX 0.09
  • PT 0.06
  • MACD
  • BRTX -0.01
  • PT 0.02
  • Stochastic Oscillator
  • BRTX 33.33
  • PT 90.33

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: